Ripah International University
Faisalabad, Punjab Province, 3800, Pakistan
NCT Number: NCT05449210
In the study , the researchers will investigate the reliability and validity of Urdu version Parkinson's Disease Questionnaire in Pakistani population having Parkinsonism
Looking for future studies?
Notify Me30 year–80 year
All sexes
Observational
Faisalabad, Punjab Province, 3800, Pakistan
The study is aimed to translate and culturally adapt Parkinson's Disease Questionnaire-39 into Urdu language and to investigate validity and reliability of Parkinson's Disease Questionnaire-39 in Parkinson's diseased patient among Pakistani population.The study will be a cross sectional survey in which non-probability purposive sampling technique will be used to enroll the participants into the study as per criteria.
The results of the study will help to establish an understanding of validity and reliability of Urdu version of Parkinson's Disease Questionnaire-39 with quality of life of Parkinson's Disease patients in Pakistani population having Parkinson's Disease. Reliability of the scale will be checked through internal consistency and test-retest methods. Cronbach's alpha value will be used to analyze internal consistency and for analyzing test-retest reliability an intraclass correlation coefficient with 195 patients will be used
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12th Week
The Parkinson's Disease Questionnaire checks the quality of life of patients suffering from Parkinson Disease
Riphah International University
Other
Reliability and Validity of Urdu Version of Parkinson's Disease Questionnaire in Pakistani Parkinson's Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06230926
Basal Ganglia Diseases, Brain Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05538455
Alzheimer Disease, Basal Ganglia Diseases
Milan, MI, Italy
View Trial DetailsNCT04215900
Basal Ganglia Diseases, Brain Diseases
Coral Gables, Florida, United States
View Trial DetailsNCT04928833
Balance, Basal Ganglia Diseases
Güneysu, Rize Province, Turkey (Türkiye)
View Trial Details